Effectiveness of IL-23 Inhibitor Guselkumab in Real-World Chinese Patients with Psoriasis During a 20-Week Period

Chan, Y; Tong, BSB; Ngan, PY; Au, CS

Chan, Y (corresponding author), Room 1103-06,11-F Hong Kong Pacific Ctr, Hong Kong, Peoples R China.

PSORIASIS-TARGETS AND THERAPY, 2021; 11 (): 53

Abstract

Background: Interleukin-23 inhibitors are novel treatment options for psoriasis, and their efficacy and safety have been widely demonstrated in phase ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索